Showing results (421-430 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|December 7, 2018
Patients carrying CYP2C8*3 have shorter systemic paclitaxel exposureLauren A Marcath, Kelley M Kidwell, Adam C Robinson, et al.
Pharmacogenomics|March 28, 2018
From Homer and Hippocrates to modern personalized medicine: is there a role for pharmacoepigenomics in the treatment of alcohol addiction?Georgia Ragia, Vangelis G Manolopoulos
Pharmacogenomics|October 11, 2007
Pharmacogenomics research involving racial classification: qualitative research findings on researchers' views, perceptions and attitudes towards socioethical responsibilitiesNathalie Egalité, Vural Ozdemir, Béatrice Godard
Pharmacogenomics|October 11, 2007
C-440T/T-331C polymorphisms in the UGT1A9 gene affect the pharmacokinetics of mycophenolic acid in kidney transplantationSara Baldelli, Simona Merlini, Norberto Perico, et al.
Pharmacogenomics|October 11, 2007
CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patientsSeung-Hyun Kim, Young-Min Ye, Gyu Young Hur, et al.
Pharmacogenomics|October 11, 2007
Advances in pharmacogenomics of antiretrovirals: an updateQing Ma, Dan Brazeau, Alan Forrest, et al.
Pharmacogenomics|October 11, 2007
The promise of gene therapy for the treatment of alpha-1 antitrypsin deficiencyPedro E Cruz, Christian Mueller, Terence R Flotte
Pharmacogenomics|October 11, 2007
Pharmacogenetic significance of inosine triphosphataseJörgen Bierau, Martijn Lindhout, Jaap A Bakker
Pharmacogenomics|October 11, 2007
Novel methods for detecting epistasis in pharmacogenomics studiesAlison A Motsinger, Marylyn D Ritchie, David M Reif
Pharmacogenomics|November 24, 2007
Conceptual basis and methodology of the SOPHIA studyN Glorioso, G Argiolas, F Filigheddu, et al.
Pageof 276